Literature DB >> 10565954

Posttreatment follow-Up of brucellosis by PCR assay.

P Morata1, M I Queipo-Ortuño, J M Reguera, M A García-Ordoñez, C Pichardo, J D Colmenero.   

Abstract

In order to evaluate the usefulness of a peripheral blood PCR assay in the posttreatment follow-up of brucellosis, a cohort of 30 patients was studied by means of blood cultures, rose Bengal, seroagglutination, Coombs' antibrucella tests, and PCR assay at the time of diagnosis, at the end of treatment, and 2, 4, and 6 months later. Of the 29 patients whose PCR assays were initially positive, 28 (96.5%) were negative at the conclusion of the treatment. PCR was positive for the two patients who had relapses and negative for another four who had suspected but unconfirmed relapses. PCR was negative for 98.3% of the follow-up samples from those patients who had a favorable evolution. In conclusion, PCR appears to be a very useful technique, not only for the initial diagnosis of the disease, but also for posttreatment follow-up and the early detection of relapses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10565954      PMCID: PMC85913     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Complications associated with Brucella melitensis infection: a study of 530 cases.

Authors:  J D Colmenero; J M Reguera; F Martos; D Sánchez-De-Mora; M Delgado; M Causse; A Martín-Farfán; C Juárez
Journal:  Medicine (Baltimore)       Date:  1996-07       Impact factor: 1.889

2.  Strategy for optimizing DNA amplification in a peripheral blood PCR assay used for diagnosis of human brucellosis.

Authors:  P Morata; M I Queipo-Ortuño; J de Dios Colmenero
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

Review 3.  An overview of human brucellosis.

Authors:  E J Young
Journal:  Clin Infect Dis       Date:  1995-08       Impact factor: 9.079

4.  Multivariate model for predicting relapse in human brucellosis.

Authors:  J Solera; E Martínez-Alfaro; A Espinosa; M L Castillejos; P Geijo; M Rodríguez-Zapata
Journal:  J Infect       Date:  1998-01       Impact factor: 6.072

5.  Treatment of human brucellosis with doxycycline and gentamicin.

Authors:  J Solera; A Espinosa; E Martínez-Alfaro; L Sánchez; P Geijo; E Navarro; J Escribano; J A Fernández
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Rapid diagnosis of human brucellosis by peripheral-blood PCR assay.

Authors:  M I Queipo-Ortuño; P Morata; P Ocón; P Manchado; J D Colmenero
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  [Brucellosis after treatment: the diagnosis of recurrences].

Authors:  S Martín Moreno; L Guinea Esquerdo; P Carrero González; R Visedo Orden; S García Carbajosa; T Calvo del Olmo; D Reverte Cejudo
Journal:  Med Clin (Barc)       Date:  1992-05-30       Impact factor: 1.725

8.  [Meta-analysis of the efficacy of the combination of +rifampicin and doxycycline in the treatment of human brucellosis].

Authors:  J Solera; E Martínez-Alfaro; L Sáez
Journal:  Med Clin (Barc)       Date:  1994-05-21       Impact factor: 1.725

9.  Detection of Brucella melitensis and Brucella abortus by DNA amplification.

Authors:  G G Baily; J B Krahn; B S Drasar; N G Stoker
Journal:  J Trop Med Hyg       Date:  1992-08

10.  Characteristics of and risk factors for relapse of brucellosis in humans.

Authors:  J Ariza; J Corredoira; R Pallares; P F Viladrich; G Rufi; M Pujol; F Gudiol
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

View more
  14 in total

1.  Diagnostic yield of a PCR assay in focal complications of brucellosis.

Authors:  P Morata; M I Queipo-Ortuño; J M Reguera; F Miralles; J J Lopez-Gonzalez; J D Colmenero
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 2.  Laboratory Diagnosis of Human Brucellosis.

Authors:  Pablo Yagupsky; Pilar Morata; Juan D Colmenero
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

3.  Evaluation of different PCR assays for early detection of acute and relapsing brucellosis in humans in comparison with conventional methods.

Authors:  Stella Mitka; Constantine Anetakis; Efimia Souliou; Eudoxia Diza; Athina Kansouzidou
Journal:  J Clin Microbiol       Date:  2007-01-31       Impact factor: 5.948

4.  Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene.

Authors:  Svetlana Bardenstein; Michal Mandelboim; Thomas A Ficht; Miriam Baum; Menachem Banai
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

5.  Chronic brucellosis and persistence of Brucella melitensis DNA.

Authors:  Maria Jesús Castaño; Javier Solera
Journal:  J Clin Microbiol       Date:  2009-05-06       Impact factor: 5.948

6.  Development and evaluation of a PCR-enzyme-linked immunosorbent assay for diagnosis of human brucellosis.

Authors:  Pilar Morata; María I Queipo-Ortuño; Jose M Reguera; Miguel A García-Ordoñez; Ana Cárdenas; Juan D Colmenero
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

7.  BrucellaCapt versus classical tests in the serological diagnosis and management of human brucellosis.

Authors:  Aurora Casanova; Javier Ariza; Manuel Rubio; Cristina Masuet; Ramón Díaz
Journal:  Clin Vaccine Immunol       Date:  2009-04-15

8.  Application of a polymerase chain reaction enzyme immunoassay in peripheral whole blood and serum specimens for diagnosis of acute human brucellosis.

Authors:  G Vrioni; C Gartzonika; A Kostoula; C Boboyianni; C Papadopoulou; S Levidiotou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

9.  Diagnosis of canine brucellosis: comparison between serological and microbiological tests and a PCR based on primers to 16S-23S rDNA interspacer.

Authors:  L B Keid; R M Soares; N R Vieira; J Megid; V R Salgado; S A Vasconcellos; M da Costa; F Gregori; L J Richtzenhain
Journal:  Vet Res Commun       Date:  2007-02-16       Impact factor: 2.816

Review 10.  Laboratory exposures to brucellae and implications for bioterrorism.

Authors:  Pablo Yagupsky; Ellen Jo Baron
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.